Aggregation of unilamellar lecithin liposomes induced by cyclosporin. 1986

L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
Department of Clinical Biochemistry, Banting Institute, Faculty of Medicine, University of Toronto, Ontario, Canada.

Small unilamellar [14C]lecithin liposomes prepared in the presence of cyclosporin sedimented at 12,000 g. Sepharose 4B gel filtration of the resuspended pellet and supernatant yielded identical peaks consisting of small unilamellar liposomes containing cyclosporin. The column retained 40-50 per cent of 14C-labelled liposomes prepared in the presence of cyclosporin as liposome aggregates.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier

Related Publications

L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
July 1993, Biochemistry,
L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
November 1980, Journal of biochemistry,
L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
June 1980, Biochemical and biophysical research communications,
L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
January 1984, Biofizika,
L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
May 2009, Bioscience, biotechnology, and biochemistry,
L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
January 1989, Biofizika,
L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
March 1999, Journal of colloid and interface science,
L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
March 1997, Journal of colloid and interface science,
L Stuhne-Sekalec, and J Chudzik, and N Z Stanacev
June 2002, Radiation research,
Copied contents to your clipboard!